PAI-1 polymorphisms also modulate the risk of colorectal cancer (CRC) in a manner that is dependent on other clinical pathologic factors such as age, presence or absence of HTN, presence or absence of DM, obesity, folate levels, and homocysteine levels. This evidence concerns the gene SERPINE1 and colorectal carcinoma.